Related Experiment Video

Updated: Aug 19, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

[New therapeutic approaches to Cystic fibrosis]

J-M Willemot1, I Sermet Gaudelus, G Lenoir

  • 1Association ABCF Protéine, hôpital Necker Enfants Malades, Paris.

Annales Pharmaceutiques Francaises
|July 5, 2003
PubMed

Insights

Researchers are exploring new cystic fibrosis transmembrane conductance regulator (CFTR) therapies. These strategies include gene therapy and drugs that restore CFTR function or bypass it, offering hope for lung disease treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Pharmacology

Context:

  • Cystic fibrosis (CF) research has advanced significantly since identifying the defective CFTR gene.
  • Understanding CFTR function and gene expression is crucial for developing effective treatments.
  • Lung disease progression in CF is linked to CFTR dysfunction.

Purpose:

  • To review current therapeutic strategies for cystic fibrosis.
  • To discuss gene therapy and pharmacological approaches targeting CFTR.
  • To explore agents that restore CFTR function or bypass its activity.

Summary:

  • Gene therapy and pharmacological agents are being developed to treat cystic fibrosis.
  • Some agents aim to restore function to specific CFTR mutations.
  • Other molecules bypass CFTR, offering alternative therapeutic avenues.

Impact:

  • These investigations aim to improve treatment outcomes for individuals with cystic fibrosis.
  • The development of novel therapies could significantly impact lung health in CF patients.
  • This review provides an overview of promising therapeutic strategies for CF management.

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...